Clinical Trial Update: Rasburicase in Patients at Risk for Tumor Lysis Syndrome [Phase 2]

View source ↗

Summary

This clinical trial update reports results from a Phase 2 study of rasburicase in patients at risk for tumor lysis syndrome, which has completed and posted resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tumor Lysis Syndrome

Drugs mentioned

• Rasburicase (rasburicase)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Tumor Lysis Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2013-08-01